QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: dmd.104.000646v1 32/12/1351    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Iwata, H. Articles by Watabe, T. Search for Related Content PubMed PubMed Citation Articles by Iwata, H. Articles by Watabe, T.

IDENTIFICATION AND CHARACTERIZATION OF POTENT CYP3A4 INHIBITORS IN SCHISANDRA FRUIT EXTRACT

Division of Natural Products Chemistry, Institute of Natural Medicine, Toyama Medical and Pharmaceutical University, Toyama, Japan (H.I., Y.T., S.K.); Division of Analysis and Metabolism, Kashima Laboratory, Mitsubishi Chemical Safety Institute Ltd., Ibaraki, Japan (H.I.); Department of Drug Metabolism and Molecular Toxicology, Tokyo University of Pharmacy and Life Science, Tokyo, Japan (A.H., T.W.); and Department of Molecular Toxicology, Nihon Pharmaceutical University, Saitama, Japan (T.W.)

Schisandra fruit, a Schisandraceae family herb, is used as a component in Kampo medicines (developed from Chinese medicines, but established in Japan). It can act as a sedative and antitussive, improve hepatic function, and give a general tonic effect. An extract of Schisandra fruit has been shown with a potent inhibitory effect on human liver microsomal erythromycin N-demethylation activity mediated by cytochrome P450 3A4 (CYP3A4). The present study was conducted to identify Schisandra fruit components having inhibitory effects on CYP3A4 by surveying the effect on human liver microsomal erythromycin N-demethylation activity. Known components of Schisandra fruit, gomisins B, C, G, and N and -shizandrin, showed inhibitory effects on N-demethylation activity. Among these components, gomisin C displayed the most potent and competitive inhibitory effect, with a K_i value of 0.049 µM. Furthermore, the inhibitory effect of gomisin C was stronger than that of ketoconazole (K_i = 0.070 µM), a known potent CYP3A4 inhibitor. Gomisin C, however, inhibited CYP1A2-, CYP2C9-, CYP2C19-, and CYP2D6-dependent activities only to a limited extent (IC₅₀ values >10 µM). Moreover, gomisin C inactivated human liver microsomal erythromycin N-demethylation activity in a time- and concentration-dependent manner. The inactivation kinetic parameters k_inact and K_I were 0.092 min^-1 and 0.399 µM, respectively. The human liver microsomal erythromycin N-demethylation activity inactivated by gomisin C did not recover on dialysis of the microsomes. Spectral scanning of CYP3A4 with gomisin C yielded an absorbance at 455 nm, suggesting that gomisin C inactivated the cytochrome P450 via the formation of a metabolite intermediate complex. This pattern is consistent with the metabolism of the methylenedioxy substituent in gomisin C. These results indicate that gomisin C is a mechanism-based inhibitor that not only competitively inhibits but irreversibly inactivates CYP3A4.

This article has been cited by other articles:

				N. Kinoshita, Y. Yamaguchi, X.-L. Hou, K. Takahashi, and K. Takahashi Experimental Adjustment on Drug Interactions through Intestinal CYP3A Activity in Rat: Impacts of Kampo Medicines Repeat Administered Evid. Based Complement. Altern. Med., November 1, 2009; (2009) nep159v1. [Abstract] [Full Text] [PDF]

				F. Qiu, R. Zhang, J. Sun, J. A, H. Hao, Y. Peng, H. Ai, and G. Wang Inhibitory Effects of Seven Components of Danshen Extract on Catalytic Activity of Cytochrome P450 Enzyme in Human Liver Microsomes Drug Metab. Dispos., July 1, 2008; 36(7): 1308 - 1314. [Abstract] [Full Text] [PDF]

				H. Greenlee, C. Atkinson, F. Z. Stanczyk, and J. W. Lampe A Pilot and Feasibility Study on the Effects of Naturopathic Botanical and Dietary Interventions on Sex Steroid Hormone Metabolism in Premenopausal Women Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1601 - 1609. [Abstract] [Full Text] [PDF]

				H. Kim, Y.-J. Yoon, J.-H. Shon, I.-J. Cha, J.-G. Shin, and K.-H. Liu INHIBITORY EFFECTS OF FRUIT JUICES ON CYP3A ACTIVITY Drug Metab. Dispos., April 1, 2006; 34(4): 521 - 523. [Abstract] [Full Text] [PDF]

				S. Tsukamoto, M. Aburatani, and T. Ohta Isolation of CYP3A4 Inhibitors from the Black Cohosh (Cimicifuga racemosa) Evid. Based Complement. Altern. Med., June 1, 2005; 2(2): 223 - 226. [Abstract] [Full Text] [PDF]